Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin® (trastuzumab)*, is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists selected Dr. Ullrich, who on September 8 will receive a $100,000 prize during a ceremony in Beerse, Belgium./nTo view Multimedia News Release, go to http://www.prnewswire.com/mnr/pauljanssenaward/38987/

Added: 01-07-2009
Runtime: 5m 12s
Views: 182
Comments: 0

Login to Rate Video

Current Rating:
Not yet rated
(0 Votes)